Source link : https://newshealth.biz/health-news/restarting-selumetinib-promising-for-recurrent-low-grade-glioma-in-kids/
At the International Symposium on Pediatric Neuro-Oncology (ISPNO), investigators reported prospective evidence supporting retreatment with the MEK inhibitor selumetinib (Koselugo) in children with recurrent low-grade glioma. In this MedPage Today video, Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, discusses the findings and why they offer compelling evidence as to why retreatment […]
The post Restarting Selumetinib Promising for Recurrent Low-Grade Glioma in Kids first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-15 19:34:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8